☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Menarini
Menarini Entered into an Exclusive License Agreement with Astellas to Commercialize Smyraf in Taiwan and Selected South-East Asian...
September 14, 2023
Menarini Reports EMA's Validation of MAA for Elacestrant to Treat ER+/HER2- Advanced or Metastatic Breast Cancer
August 19, 2022
Glenmark's Ryaltris Nasal Spray Receives EC's Approval as 1L Treatment for Allergic Rhinitis
April 27, 2021
Load more...
Back to Home